Cancer Testing - G2 Intelligence

PGx Testing: First, Do No Harm

Recent advances in pharmacogenomic testing—and their role in ensuring safe, effective treatment selection for precision oncology

Start a Free Trial for immediate access to this article

Already a member? Log in here

When it comes to cancer, patients’ greatest fear is diagnostic delays—and they believe digital pathology and AI can reduce those delays

Start a Free Trial for immediate access to this article

Already a member? Log in here

The company is hiring at least 100 sales representatives this year to spread awareness and uptake of its recently FDA-approved Shield test

Start a Free Trial for immediate access to this article

Already a member? Log in here

The current landscape of molecular hematopathology—and what steps clinical labs can take to stay at the forefront of the discipline

Start a Free Trial for immediate access to this article

Already a member? Log in here

Multicancer early detection tests—and their promise of comprehensive, minimally invasive screening—are catching the eye of labs and lawmakers

Start a Free Trial for immediate access to this article

Already a member? Log in here